Health Care·Health Care Equipment·$13.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.02 | N/A | -50.60% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.02 | N/A | -50.60% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management acknowledged the difficulties faced in the quarter, particularly regarding EPS. They remain focused on future growth opportunities.
Management noted challenges in meeting EPS expectations.
They emphasized a focus on long-term growth despite short-term setbacks.
Insulet Corp's earnings report showed a significant miss on EPS, which contributed to a 2.45% decline in stock price. The lack of revenue figures and guidance may raise concerns among investors about the company's short-term performance. Management's cautious tone suggests they are aware of the challenges but remain focused on long-term growth strategies.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SEMPRA
Aug 2, 2019